What we choose to study—whether fine art or finance—is one of the most influential decisions in our lives. It shapes not only ...

Fintel reports that on November 4, 2025, TD Cowen maintained coverage of Myriad Genetics (NasdaqGS:MYGN) with a Hold ...

In the largest genetic analysis of polycystic ovary syndrome to date, scientists have identified new variants linked to the ...

What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 19.3% in the morning session after it ...

Mr. Brady became the latest celebrity to try to preserve a pet’s genetics, a move that animal rights groups have criticized.

Alastair Reeves has followed in his father's footsteps, using genetics to help farmers solve problems on farm by breeding ...

Heart disease in families is a warning, not a destiny. While genes play a role, lifestyle choices hold immense power. Knowing ...

Research on human brain organoids (HBOs) is directly challenging how biobanks and biomedical institutes recruit volunteers.

Genetic testing is transforming healthcare through personalized medicine, enabling early diagnosis, targeted treatments, and a future of more precise, patient-centered care.

The neurologic disease called chronic traumatic encephalopathy or CTE has most often been found in people who experienced repeated blows to the head while playing contact sports and there’s now ...

Analysts estimate that Myriad Genetics will report an earnings per share (EPS) of $-0.05. The announcement from Myriad Genetics is eagerly anticipated, with investors seeking news of surpassing ...

For the first time, a research team led by the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has mapped the genetic architecture of a ...